340B covered entities are expanding contracts with retail pharmacies that are increasingly located in counties with high rates of Medicare and Medicaid insurance coverage. The 340B Drug Pricing ...
The federal 340B Drug Pricing Program ("340B Program") was created by Congress in 1992 through an amendment to the Public Health Service Act. [i] The program, which is administered by the Health ...
In a bipartisan spending agreement that was largely negotiated behind closed doors, Congress included a policy change with ...
Five companies account for 76.1% of the 340B contract pharmacy market, according to Drug Channels. Since Congress established the 340B program in 1992, the program has expanded to include 32,069 ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...
Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...
The Well News on MSNOpinion

340B has gone off the rails

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have ...
Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under ...
More than three decades ago, Congress created the 340B program to help safety-net hospitals and clinics expand resources and care for underserved communities. By requiring pharmaceutical companies to ...
A U.S. federal judge has rejected challenges by two pharmaceutical manufacturers seeking to block a Maine law that regulates the use of contract pharmacies under the federal 340B drug discount program ...
Add Yahoo as a preferred source to see more of our stories on Google. In a recent opinion piece, it was suggested the federal 340B Drug Pricing Program is contributing to rising employer health-care ...